Related Articles
Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice
Plasminogen activator inhibitor-1 in kidney pathology (Review)
Binding site of amiloride to urokinase plasminogen activator depends on species
REDUCTION OF TUMOR-ASSOCIATED FIBRINOLYTIC-ACTIVITY BY ANTIMETASTATIC DOSAGES OF 2 RU(II)-DMSO COMPLEXES IN MICE BEARING LEWIS LUNG-CARCINOMA
Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure